Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

OnabotulinumtoxinA (Botox) Effect on Pain and Return to Sport in Chronic Exertional Compartment Syndrome of the Anterior Leg: A Pilot Study

Next Previous
Search
Trial Profile

OnabotulinumtoxinA (Botox) Effect on Pain and Return to Sport in Chronic Exertional Compartment Syndrome of the Anterior Leg: A Pilot Study

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 20 Feb 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Compartment syndrome; Musculoskeletal pain
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 08 Feb 2023 Status changed from completed to discontinued, due to COVID-19.
  • 26 Apr 2022 Status changed from recruiting to completed.
  • 13 Aug 2021 The primary endpoint was changed from Decrease in pain as assessed by change in Sliding pain scale to Change in Pain Score, Number of Participants with Lower Extremity Weakness, and Incidence of Adverse Events, according to ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top